TGA Archives | Page 7 of 11 | Cannabiz

SAS-B deep dive: half-year data illustrates shifting sands as monthly approvals hit almost 20,000

by Steve Jones July 3, 2024July 3, 2024

Doctors are increasingly prescribing medicinal cannabis to patients with anxiety, sleep disorders and depression, a half-year […]

medical cannabis for children

Cannabinoid drug developer holds ‘positive’ talks with TGA as hopes rise of fast-tracking ARTG listing

by Steve Jones June 28, 2024June 28, 2024

Releaf Group and Botanic Wellness among six firms hit with TGA fines

by Steve Jones June 26, 2024June 27, 2024

Federal court adjourns TGA advertising case against Montu

by Steve Jones June 7, 2024June 13, 2024

TGA fines Melbourne pharmacy $171k for alleged advertising offences

by Steve Jones May 24, 2024May 24, 2024

Dolphins agree to ditch Alternaleaf branding from jerseys and stadiums

by Steve Jones May 13, 2024May 16, 2024

First court date set as TGA and Montu prepare for legal fight

by Steve Jones May 8, 2024July 16, 2024

Pastilles gaining in popularity as SAS-B approvals maintain strong start to 2024

by Steve Jones May 6, 2024July 16, 2024

‘Protectionism doesn’t work’, Biortica chief warns as industry urged to take collaborative approach on imports

by Steve Jones May 1, 2024May 1, 2024

Dolphins’ Alternaleaf blackout piles more pressure on Montu amid TGA legal action

by Steve Jones April 24, 2024April 24, 2024